Fagan Associates’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,940
| Closed | -$4.25M | – | 120 |
|
|
2024
Q1 | $4.25M | Sell |
30,940
-536
| -2% | -$73.6K | 0.8% | 40 |
|
|
2023
Q4 | $4.28M | Sell |
31,476
-834
| -3% | -$113K | 0.93% | 33 |
|
|
2023
Q3 | $3.95M | Sell |
32,310
-1,068
| -3% | -$131K | 0.96% | 33 |
|
|
2023
Q2 | $4.24M | Sell |
33,378
-326
| -1% | -$41.4K | 1.03% | 29 |
|
|
2023
Q1 | $4.35M | Sell |
33,704
-734
| -2% | -$94.8K | 1.08% | 30 |
|
|
2022
Q4 | $4.52M | Buy |
34,438
+14,437
| +72% | +$1.9M | 1.21% | 29 |
|
|
2022
Q3 | $2.34M | Sell |
20,001
-188
| -0.9% | -$22K | 0.65% | 41 |
|
|
2022
Q2 | $2.38M | Buy |
20,189
+178
| +0.9% | +$20.9K | 0.63% | 42 |
|
|
2022
Q1 | $2.61M | Buy |
20,011
+697
| +4% | +$90.8K | 0.53% | 51 |
|
|
2021
Q4 | $2.95M | Buy |
+19,314
| New | +$2.95M | 0.56% | 51 |
|